Aging is associated with a decline in immune function, generally termed immunosenescence ([@bib12]; [@bib9]), which in turn is often linked to age-related increases in oxidative stress ([@bib16]). Oxidative stress associated with aging has been attributed to the initiation and maintenance of chronic low-grade inflammation ("inflammaging"; [@bib9]). A consequence of immunosenescence is that many viral infections are more severe in aged individuals ([@bib14]; [@bib5]; [@bib57]; [@bib1]). Age-dependent changes in susceptibility are especially striking in patients with the severe acute respiratory syndrome (SARS) or the recently identified Middle East respiratory syndrome (MERS), both caused by coronaviruses (SARS-CoV or MERS-CoV). In the 2002--2003 SARS epidemic, all patients under 24 yr of age survived, whereas 6, 15, and \>50% of patients aged 25--44, 45--64, and \>65 yr of age, respectively, succumbed to the infection, with many developing acute respiratory distress syndrome ([@bib18]; [@bib51]; [@bib14]). This marked age-dependent increase in mortality is also observed in mice and nonhuman primates infected with SARS-CoV ([@bib50]; [@bib15]; [@bib61]; [@bib24]). For example, 6--10-wk-old C57BL/6 mice are highly resistant to SARS-CoV and remain asymptomatic even in the absence of interferon signaling ([@bib23]), whereas as mice age from 6 wk to 22 mo they become progressively more susceptible to the infection ([@bib68]).

Mice that succumb to SARS-CoV often develop poor T cell responses ([@bib67]; [@bib13]). T cell priming to SARS-CoV requires migration of respiratory DCs (rDCs) from the lungs to the mediastinal LNs (MLN). Primed T cells then migrate back to the lungs. We previously showed that rDC migration was greatly decreased in uninfected and SARS-CoV--infected aged compared with young mice. Concomitant with this decreased rDC migratory capacity was an increase in prostaglandin D~2~ (PGD~2~) in the lungs ([@bib68]). PGD~2~, an eicosanoid with both proinflammatory and antiinflammatory/proresolving properties is a downstream metabolite of arachidonic acid (AA; [@bib58]; [@bib56]; [@bib62]; [@bib59]). PGD~2~ binds to two different G-protein--coupled receptors: DP1 expressed on macrophages and DCs (antiinflammatory) and DP2 expressed on Th2 cells (proinflammatory). PGD~2~ signaling through the DP1 receptor on respiratory DCs (rDCs) and alveolar macrophages (AMs) in the naive and virus-infected lung, results in, among other effects, decreased CCR7 expression ([@bib31]; [@bib68]). This, in turn, results in decreased rDC migration from the lungs to the MLN and poor T cell responses.

To determine the factors behind age-related increases in PGD~2~ levels in the lungs, we initially focused on gene expression in CD11c^+^ cells (AM and rDC) since these cells are key modulators of the immune response in the lungs. We used middle aged (10--13 mo) mice, since these mice, like middle-aged SARS patients, are much more susceptible to the infection than young (6--8 wk) mice, but have not yet developed many of the features of immunosenescence observed in aged (\>18 mo animals) and are easier to obtain. Analysis of several genes involved in AA metabolism and oxidative stress in the lungs revealed, most strikingly, that levels of a phospholipase, PLA~2~G2D, increased as mice aged. Phospholipases hydrolyze phospholipids to release long-chain fatty acids that are further metabolized sequentially by cyclooxygenases and synthases to yield various lipid mediators. In particular, PLA~2~G2D is an enzyme that predominantly contributes to antiinflammatory/proresolving lipid mediator expression ([@bib46]). Therefore, we reasoned that age-related increases in PLA~2~G2D could contribute to a delayed immune response and poor outcomes after SARS-CoV infection by up-regulating expression of such lipid mediators. Here, we identified age-related alterations in PLA~2~G2D expression in the lungs of uninfected and SARS-CoV--infected mice. Infection of middle-aged mice lacking PLA~2~G2D expression (*Pla2g2d*^−/−^) with SARS-CoV resulted in enhanced DC migration to the MLN and antiviral T cell responses, more rapid virus clearance and most remarkably, significantly decreased mortality compared with wild-type (*Pla2g2d*^+/+^) mice.

RESULTS
=======

PLA~2~G2D is expressed preferentially in CD11c^+^ cells in lungs
----------------------------------------------------------------

Because chronic inflammation in the lung increases with aging ([@bib44]) and AM and rDC (CD11c^+^ cells) are critical for maintaining lung homeostasis and for prostaglandin production, we initially examined CD11c^+^ cells harvested from young and middle-aged mice for global changes in gene expression. Expression levels of 186 genes changed during aging, with many involved in antigen presentation and inflammation ([Fig. 1 B](#fig1){ref-type="fig"} and [Table S1](http://www.jem.org/cgi/content/full/jem.20150632/DC1){#supp1}). Many of these were predicted to contribute to a chronic inflammatory response. However, our previous study showed that levels of a prostaglandin with antiinflammatory properties, PGD~2~, were elevated in aged mice (confirmed in [Fig. 1 A](#fig1){ref-type="fig"}) and contributed to poor outcomes after SARS-CoV infection ([@bib68]). Therefore, we next focused on genes involved in the AA pathway, including several phospholipases, cyclooxygenases, and synthases, which could modulate PGD~2~ levels in the lungs. Of all the genes in the AA cascade, only levels of secreted phospholipase A~2~ group IID (PLA~2~G2D*)* were significantly higher in CD11c^+^ cells in the lungs of middle-aged compared with young mice (using twofold differences as a cutoff; [Fig. 1, C and D](#fig1){ref-type="fig"}). We confirmed these results by quantitative real-time PCR (qPCR) analyses of CD11c^+^ cell RNA by separating CD11c^+^ and CD11c^−^ cells from the lungs of naive young and middle-aged mice using magnetic beads and quantifying the expression of PLA~2~G2D mRNA ([Fig. 2 A](#fig2){ref-type="fig"}). We observed 25--30 fold higher expression of PLA~2~G2D mRNA in lung CD11c^+^ compared with CD11c^−^ cells from middle-aged mice. Comparison of CD11c^+^ cells from young and middle-aged mice revealed that PLA~2~G2D was expressed at levels \>50-fold higher in middle-aged mice ([Fig. 2 A](#fig2){ref-type="fig"}). Flow cytometric analysis also showed higher expression of PLA~2~G2D in CD11c^+^ compared with CD11c^−^ cells on a per cell basis in both young and middle-aged mice, as measured by mean fluorescent intensity (MFI; [Fig. 2 B](#fig2){ref-type="fig"}). In addition, middle-aged mice harbored a higher frequency of CD11c^+^ cells expressing PLA~2~G2D compared with young mice ([Fig. 2 C](#fig2){ref-type="fig"}).

![**Differential gene expression in pulmonary CD11c^+^ cells from middle-aged and young mice.** (A) Lungs from naive young (6--8 wk) and middle-aged (10--13 mo) C57BL/6 mice were analyzed for PGD~2~ expression by LC/MS analysis. Mean ± SEM; two independent experiments, five mice/group. \*, P \< 0.05, unpaired Student's *t* test. (B) Heat map depicting differential gene expression in pulmonary CD11c^+^ cells from young and middle-aged mice. (C and D) Heat map and table depicting differential expression of genes involved in AA metabolism in pulmonary CD11c^+^ cells. Table shows step-up p-value (after correcting for multiple comparisons), fold change, and mean expression values of different genes (*n* = 4/group).](JEM_20150632_Fig1){#fig1}

![**PLA~2~G2D expression in CD11c cells in the lungs and MLN of middle-aged mice.** (A) PLA~2~G2D mRNA levels in CD11c^−^ and CD11c^+^ cells from the lungs of young and middle-aged mice. CD11c^+^ and CD11c^−^ cells were prepared from the lungs of naive young or middle--aged mice using CD11c magnetic beads and analyzed for PLA~2~G2D mRNA levels using qPCR. Mean ± SEM; two independent experiments, eight mice/group. \*\*\*, P \< 0.001, unpaired Student's *t* test. (B) Representative histograms comparing the mean fluorescent intensity of PLA~2~G2D expression in CD11c^−^ and CD11c^+^ cells (gated on CD45^+^ cells) of young and middle aged mice (left). Summary data are shown on right. Single-cell suspension from the lungs of naive young and middle-aged mice were stained for PLA~2~G2D and analyzed by flow cytometry as described in the Materials and methods. Mean ± SEM; three independent experiments, four mice/group. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001, unpaired Student's *t* test. (C) Frequency of CD11c^+^ cells (gated on CD45^+^) expressing PLA~2~G2D in the lungs of naive young and middle aged mice. The boxed area in the flow cytometry plots indicates cell populations staining positive for PLA~2~G2D. Mean ± SEM; three independent experiments, four mice/group. \*, P \< 0.05, unpaired Student's *t* test. (D) Frequency and total number of FoxP3^+^ CD4^+^ T reg cells (gated on CD3^+^CD8^−^). Mean ± SEM; two independent experiments, four mice/group. \*\*, P \< 0.01, unpaired Student's *t* test. (E) PLA~2~G2D expression in absence of CD4 T cells. (left) Extent of depletion of CD4 T cells on day 4 after GK1.5 treatment; (right) mRNA expression of PLA~2~G2D in the lungs of treated (GK1.5) and control groups. CD4 T cells were depleted using mAb GK1.5, delivered i.p. at 0.5 mg/mouse on day 0 and 2. 2 d later, lungs were harvested into TRIzol for quantifying PLA~2~G2D RNA levels. PBS was administered to control mice. Mean ± SEM; two independent experiments, four mice/group. n.s., not significant, unpaired Student's *t* test. (F) CD11c^+^ and CD11c^−^ cells were harvested from the MLN of naive young and middle-aged mice. PLA~2~G2D mRNA levels were determined using qPCR. Mean ± SEM; two independent experiments, four mice/group. n.s., not significant; \*\*\*, P \< 0.001, unpaired Student's *t* test.](JEM_20150632_Fig2){#fig2}

Together, these results indicate that PLA~2~G2D levels are highly increased in the lungs of middle-aged mice and that CD11c^+^ cells are the major source for its production. However, regulatory T cells (T reg cells; CD4^+^FoxP3^+^) have been implicated as a source for PLA~2~G2D in previous studies ([@bib65]) and lungs of uninfected middle-aged mice harbor higher frequency and number of T reg cells compared with young mice ([Fig. 2 D](#fig2){ref-type="fig"}). To address whether T reg cells are an additional source for PLA~2~G2D, we depleted CD4 T cells, which includes T reg cells, from middle-aged mice and analyzed lungs for expression of PLA~2~G2D. We observed no changes in the mRNA expression of PLA~2~G2D after CD4 T cell depletion ([Fig. 2 E](#fig2){ref-type="fig"}), suggesting that CD4 T cells, including T reg cells, are not a major source of PLA~2~G2D in the lungs.

Because CD11c^+^ cells comprise only a minority of the total cells in the lungs, expression of PLA~2~G2D by these cells could make a relatively small contribution to its total production. However, this was not the case because levels of PLA~2~G2D were significantly higher in unfractionated lung mRNA from middle-aged compared with young mice. Notably, PLA~2~G2D levels were even higher in samples obtained from aged (22 mo) mice ([Fig. 3 A](#fig3){ref-type="fig"}). Assessment of other genes in the AA cascade generally confirmed the microarray results shown in [Fig. 1 C](#fig1){ref-type="fig"} and showed that there were no differences in the levels of expression of the cyclooxygenase enzymes COX~1~ and COX~2~ or other PLA~2~s (PLA~2~G2E, PLA~2~G3, PLA~2~G4, PLA~2~G5, and PLA~2~G10) as mice aged ([Fig. 3, B and C](#fig3){ref-type="fig"}). One exception is that there were significantly higher mRNA levels of hematopoietic PGD~2~ synthase (HPGDS), which is important for PGD~2~ production and could contribute to elevated PGD~2~ levels in the lungs of middle-aged compared with young mice ([Fig. 3 C](#fig3){ref-type="fig"}; [@bib48]).

![**Age-dependent changes in the AA cascade in the lung.** Young, middle-aged, and aged (22 mo) C57BL/6 mice were analyzed for mRNA expression levels of several enzymes in the AA pathway. (A) PLA~2~G2D mRNA levels in the lungs. Mean ± SEM; two independent experiments, four mice/group. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*,P \< 0.001, unpaired Student's *t* test. (B) mRNA levels of other phospholipases. Mean ± SEM; two independent experiments, four mice/group, unpaired Student's *t* test. (C) cyclooxygenases and hematopoietic PGD2 synthase (HPGDS) in the lungs. Mean ± SEM; two independent experiments, four mice/group. \*, P \< 0.05, unpaired Student's *t* test. All gene expression data are normalized to *Hprt* expression.](JEM_20150632_Fig3){#fig3}

Because robust expression of PLA~2~G2D in lymphoid tissue CD11c^+^ cells was previously reported ([@bib46]), we determined whether its levels increased with age in the MLN. As expected, we observed higher expression of PLA~2~G2D in CD11c^+^ compared with CD11c^−^ cells in the MLN ([Fig. 2 F](#fig2){ref-type="fig"}). However, unlike in the lungs, there were no age-dependent differences in PLA~2~G2D mRNA expression in MLN CD11c^+^ cells between young and middle-aged naive mice. Collectively, these results indicate that PLA~2~G2D is nearly exclusively expressed in CD11c^+^ cells in both lymphoid tissue and lungs and that age-related differences in its expression are confined to the lungs.

PLA~2~G2D-dependent alteration in pulmonary lipid profile
---------------------------------------------------------

PLA~2~G2D has been previously described as a proresolving phospholipase acting upstream in the AA-cascade ([@bib46]). Hence, we reasoned that higher expression levels of PLA~2~G2D in the lungs of middle-aged mice would result in perturbation in lipid metabolism and that lipid mediators with proresolving functions, other than PGD~2~, would also be produced at higher levels. To investigate this possibility, we performed electrospray ionization mass spectrometry (ESI-MS) to determine the levels of free polyunsaturated fatty acids (PUFAs), as well as their oxygenated metabolites, including PGD~2~, in the lungs of naive young and middle-aged mice ([Fig. 4, B--D](#fig4){ref-type="fig"}). Initial analyses revealed altered profiles of lipid mediators with both pro- and antiinflammatory function in the lungs of middle-aged relative to young mice. Levels of free PUFA such as AA (ω6) and docosahexaenoic acid (DHA; ω3) were not significantly different between the groups, whereas the level of eicosapentaenoic acid (EPA) was higher in middle-aged mice relative to young mice ([Fig. 4 B](#fig4){ref-type="fig"}). AA metabolites with antiinflammatory (PGE~2~ and PGD~2~) and proinflammatory properties (PGF2α and Thromboxane \[TX\] B~2~ \[a TXA~2~ metabolite\]) were produced at higher levels in the lungs of middle-aged mice compared with young mice, but levels of 6-keto-PGF1α (a PGI~2~ metabolite) did not differ between the groups ([Fig. 4, C and D](#fig4){ref-type="fig"}).

![**PLA~2~G2D-dependent alteration of lipid profile in the lungs.** Naive young and middle-aged C57BL/6 mice (B--D) and *Pla2g2d^−/−^ and Pla2g2d^+/+^* mice (E--J) were analyzed for pulmonary lipids using ESI-MS as described in Materials and methods. (A) The elution of different endogenous lipids with respect to exogenous standards (SD) is indicated. Retention times and parent m/z to daughter m/s transition are also shown. Levels of (B) free PUFAs, AA, DHA and EPA. Mean ± SEM; three independent experiments, four mice/group. n.s.*,* not significant; \*, P \< 0.05, unpaired Student's *t* test. (C) 6ketoPGF~1α~, TXB~2~, and PGF~2α~. Mean ± SEM; three independent experiments, four mice/group. n.s.*,* not significant; \*, P \< 0.05, unpaired Student's *t* test. (D) PGE~2~ and PGD~2~ in lungs of young and middle-aged C57BL/6 mice are shown. Mean ± SEM; three independent experiments, four mice/group. n.s.*,* not significant; \*, P \< 0.05, unpaired Student's *t* test. (E) Levels of free PUFAs. Mean ± SEM; two independent experiments, four mice/group, unpaired Student's *t* test. (F) 6-keto-PGF~1α~, TXB~2~, and PGF~2α~. Mean ± SEM; two independent experiments, four mice/group, unpaired Student's *t* test. (G) PGE~2~ and PGD~2~ in lungs of young *Pla2g2d^−/−^ and Pla2g2d^+/+^* mice. Mean ± SEM; two independent experiments, four mice/group, unpaired Student's *t* test. (H) Levels of free PUFAs. Mean ± SEM; two independent experiments, four mice/group, unpaired Student's *t* test. (I) 6-keto-PGF~1α~, TXB~2~, and PGF~2α~. Mean ± SEM; two independent experiments, four mice/group, unpaired Student's *t* test. (J) PGE~2~ and PGD~2~ in lungs of middle-aged *Pla2g2d^−/−^* and*Pla2g2d^+/+^* mice. Mean ± SEM; two independent experiments, four mice/group. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001, unpaired Student's *t* test.](JEM_20150632_Fig4){#fig4}

PLA~2~G2D is one of many PLA~2~ expressed in the lungs, but is the only one that was up-regulated as mice aged, as shown above. Therefore, we next assessed whether PLA~2~G2D mediated the perturbation in pulmonary lipid profile in middle-aged mice using *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice ([@bib46]). Lipid profiling of the lungs of middle-aged *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice revealed an important role for PLA~2~G2D in the levels of most lipids examined ([Fig. 4, H--J](#fig4){ref-type="fig"}). Of note, these changes were not observed when young *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice were compared ([Fig. 4, E--G](#fig4){ref-type="fig"}). AA was produced at lower levels in *Pla2g2d^−/−^* relative to *Pla2g2d^+/+^* middle-aged mice ([Fig. 4 H](#fig4){ref-type="fig"}), suggesting that phospholipase activity required to release AA was at least partly dependent on PLA~2~G2D. Levels of 6ketoPGF1α, TXB~2,~ PGF2α, PGD~2~, and PGE~2~ were also higher in the lungs of *Pla2g2d^+/+^* compared with *Pla2g2d^−/−^* mice ([Fig. 4, I and J](#fig4){ref-type="fig"}), suggesting that differences in AA levels resulted in differences in the levels of its downstream metabolites, some of which have antiinflammatory function (PGD~2~ and PGE~2~; [@bib64]; [@bib35]; [@bib48]). The results also identify PLA~2~G2D-dependent pools of two other PUFA, DHA, and EPA in the lungs. DHA and EPA are further metabolized largely into proresolving mediators, such as resolvin D1, protectin D1, and resolvin E1 among others ([@bib3]; [@bib55]).

PLA~2~G2D dependent up-regulation of PGD~2~ and other antiinflammatory lipid mediators in the lungs of SARS-CoV---infected middle-aged mice
-------------------------------------------------------------------------------------------------------------------------------------------

Having established that both proinflammatory and antiinflammatory/proresolving lipid mediators are up-regulated in the uninfected lungs of middle-aged mice, we next determined whether levels of these mediators were further perturbed in the context of infection. We initially analyzed mice infected with SARS-CoV because middle-aged but not young C57BL/6 mice succumb to infection with this virus, mimicking the human disease ([Fig. 5 A](#fig5){ref-type="fig"}; [@bib24]; [@bib69]). Because mortality in middle-aged mice begins at 4 d after SARS-CoV infection, we investigated whether levels of lipid mediators, including PGD~2~, changed at this time. Expression levels of PLA~2~G2D increased in both young and middle-aged mice after infection ([Fig. 5 B](#fig5){ref-type="fig"}). Further, pulmonary lipid profiling on day 4 postinfection (p.i.) revealed significant increases in lung levels of free PUFAs such as AA, EPA, and DHA in middle-aged mice but less so in young mice ([Fig. 5 C](#fig5){ref-type="fig"}). Levels of lipid mediators with proinflammatory activity, 6ketoPGF1α, TXB~2~, and PGF2α, increased in the lungs of young but not middle-aged mice after SARS-CoV infection ([Fig. 5 D](#fig5){ref-type="fig"}). In contrast, levels of PGE~2~ and PGD~2~, both of which have antiinflammatory activity in the lungs, increased in both young and middle-aged mice after infection ([Fig. 5 E](#fig5){ref-type="fig"}).

![**PLA~2~G2D-dependent up-regulation of PGD2 and other lipid mediators after SARS-CoV infection.** (A) Survival of young and middle-aged C57BL/6 mice after i.n. challenge with 10^4^ PFU of SARS-CoV (two independent experiments, five mice/group). Naive or infected young and middle aged C57BL/6 mice (B--E) or middle-aged *Pla2g2d^−/−^ and Pla2g2d^+/+^* mice (F--H) were analyzed for mRNA expression levels of PLA~2~G2D in and lipid expression in the lungs using qPCR and ESI-MS, respectively, as described in Materials and methods. (B) mRNA levels of PLA~2~G2D in the lungs of young and middle-aged mice before (light green) and 4 d p.i. (dark green), expressed relative to *Hprt*. Mean ± SEM; two independent experiments, four mice/group. \*, P \< 0.05; \*\*\*, P \< 0.001, unpaired Student's *t* test. Comparison of levels in the lungs of young and middle-aged mice of (C) free PUFAs, AA, DHA, and EPA. Mean ± SEM; two independent experiments, four mice/group. \#, P = 0.07; \*\*, P \< 0.01; \*\*\*, P \< 0.001, unpaired Student's *t* test. (D) 6ketoPGF~1α~, TXB~2~, and PGF~2α~. Mean ± SEM; three independent experiments, four mice/group. \*\*, P \< 0.01; \*\*\*, P \< 0.001, unpaired Student's *t* test. (E) PGE~2~ and PGD~2~ before and 4 d p.i. Mean ± SEM; three independent experiments, four mice/group. \*, P \< 0.05; \*\*, P \< 0.05; \*\*\*, P \< 0.001, unpaired Student's *t* test. Comparison of levels in the lungs of middle-aged *Pla2g2d^−/−^ and Pla2g2d^+/+^* mice of (F) free PUFAs. Mean ± SEM; two independent experiments, five mice/group. n.s.*,* not significant; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001 (unpaired Student's *t* test). (G) 6ketoPGF~1α~, TXB~2~, and PGF~2α~. Mean ± SEM; two independent experiments, five mice/group. n.s.*,* not significant; \*\*, P \< 0.01; \*\*\*, P \< 0.001, unpaired Student's *t* test. (H) PGE~2~ and PGD~2~ before and 4 d p.i. Mean ± SEM; two independent experiments, five mice/group. n.s.*,* not significant; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001 (unpaired Student's *t* test). All lipid concentrations are expressed as nanogram/milligram lung tissue.](JEM_20150632_Fig5){#fig5}

To determine whether the inducible pool of these lipids is dependent on PLA~2~G2D, we determined the lung lipid profile in SARS-CoV--infected middle-aged *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice. Whereas levels of free PUFAs, AA, DHA, and EPA increased in the lungs of both groups of mice during infection, *Pla2g2d^+/+^* mice harbored higher levels of all three fatty acids at all times examined ([Fig. 5 F](#fig5){ref-type="fig"}), indicating that the inducible pool of each of these fatty acids was at least partly mediated by PLA~2~G2D. We did not observe an infection-dependent increase in the levels of 6-keto-PGF1α, TXB~2~, or PGF2α in either group of mice, although levels remained higher in *Pla2g2d^+/+^* mice relative to *Pla2g2d^−/−^* mice on day 4 p.i. ([Figs. 4 I](#fig4){ref-type="fig"} and [5 G](#fig5){ref-type="fig"}). PGE~2~ and PGD~2~ levels increased only in *Pla2g2d^+/+^* mice after infection ([Fig. 5 H](#fig5){ref-type="fig"}). These results indicate multifactorial regulation of the inducible AA cascade with basal levels of all lipid mediators were maintained at least partly by PLA~2~G2D, whereas increases in PGE~2~ and PGD~2~ levels observed after SARS-CoV infection in the lungs were largely dependent on PLA~2~G2D. These data also agree with published studies showing that induction of PLA~2~G2D generated pools of proresolving but not proinflammatory mediators in the lung and skin in the context of allergic disease ([@bib49]; [@bib38]; [@bib42]; [@bib46]).

PLA~2~G2D plays a minor role in innate immune functions in the lungs of middle-aged mice
----------------------------------------------------------------------------------------

The preferential induction of antiinflammatory lipid mediators in *Pla2g2d^−/−^* mice could contribute to less efficient activation of the innate and adaptive immune responses. To address this possibility, we initially analyzed the activation status and function of lung CD11c^+^ cells harvested from middle-aged and young mice at day 1 after SARS-CoV infection. Cells from middle-aged mice expressed significantly higher levels of maturation markers (CD40, CD80, and MHCII) and expressed higher levels of TNF in the absence of ex vivo stimulation (basal levels) compared with young mice ([Fig. 6, A and B](#fig6){ref-type="fig"} \[RP10\]). However upon TLR stimulation with LPS or poly I:C, similar frequencies of CD11c^+^ cells from both young and middle-aged mice produced TNF, although the total number of TNF-producing cells was higher in middle-aged mice ([Fig. 6 B](#fig6){ref-type="fig"}, middle and bottom).

![**rDC activation and function in young and aged mice or *Pla2g2d^−/−^ and Pla2g2d^+/+^* mice.** Young and middle-aged C57BL/6 mice (A and B) or middle-aged *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice (C--E, G, and H) were infected with 10^4^ PFU SARS-CoV and analyzed for activation status, and functionality of pulmonary CD11c^+^ cells after TLR stimulation. (A) Expression of activation markers CD40 (top row), CD80 (middle row), and MHCII (bottom row) on lung CD11c^+^ from young and middle-aged C57BL/6 mice. Representative histograms and summary bar graphs are shown. Mean ± SEM; two independent experiments, four mice/group. \*\*, P \< 0.01; \*\*\*, P \< 0.001, unpaired Student's *t* test. (B) TNF production after vehicle (RP10, top row), LPS (middle row), or poly I:C (bottom row) stimulation is shown. Mean ± SEM; two independent experiments, four mice/group. n.s.*,* not significant. \*\*, P \< 0.01; \*\*\*, P \< 0.001, unpaired Student's *t* test. (C) Expression of activation markers CD40 (top row), CD80 (middle row), and MHCII (bottom row) on lung CD11c^+^ from middle-aged *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice. Representative histograms and summary bar graphs are shown. Mean ± SEM; two independent experiments, four mice/group. n.s.*,* not significant; \*\*, P \< 0.01, unpaired Student's *t* test. (D) TNF production after vehicle (RP10, top row), LPS (middle row), or poly I:C (bottom row) stimulation. Mean ± SEM; two independent experiments, four mice/group. n.s.*,* not significant; \*\*\*, P \< 0.001, unpaired Student's *t* test. (E) mRNA expression levels of proinflammatory cytokines, TLR3 and TLR4 in the lungs of middle-aged *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice on day 1 (left panel) and day 4 p.i. (right panel) Mean ± SEM; two independent experiments, four mice/group, unpaired Student's *t* test. N.D., not detected. (F) Naive middle-aged *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice were intranasally inoculated with 200 µg/75 µl OVA-FITC. 18 h later, MLNs were harvested and analyzed. Mean ± SEM; two independent experiments, four mice/group. \*, P \< 0.05; \*\*, P \< 0.01, unpaired Student's *t* test. (G) Frequency and number of airway DCs (CD11c^+^MHCII^+^CFSE^+^) that migrated from the lung to MLN, 18 h after SARS-CoV infection. 50 µl of 8 µM CFSE was instilled intranasally 6 h before infection. At 18 h p.i., MLNs were harvested and analyzed. Gated on CD45^+^CD11c^+^MHCII^+^CFSE^+^ cells Mean ± SEM; three independent experiments, four mice/group. \*\*, P \< 0.01, unpaired Student's *t* test. (H) MFI of CCR7 expression on rDCs in lungs (gated on CD45^+^CD11c^+^MHCII^+^CFSE^+^) 18 h p.i. Mean ± SEM; two independent experiments, four mice/group. \*, P \< 0.05, unpaired Student's *t* test.](JEM_20150632_Fig6){#fig6}

To investigate the role of PLA~2~G2D in this enhanced CD11c^+^ cell activation in middle-aged mice, we measured CD40, CD80, and MHCII levels on lung CD11c^+^ cells harvested from infected middle-aged *Pla2g2d^+/+^* and *Pla2g2d^−/−^* mice and also quantified TNF expression after TLR stimulation. PLA~2~G2D was required for MHCII but not CD40 or CD80 expression on lung CD11c^+^ cells in middle-aged mice, and for increased frequency but not number of cells expressing TNF in the absence of any direct ex vivo stimulation with TLR ligands. CD11c^+^ cells from both *Pla2g2d^+/+^* and *Pla2g2d^−/−^* mouse lungs were able to express equivalent amounts of TNF after direct ex vivo stimulation ([Fig. 6, C and D](#fig6){ref-type="fig"}). Thus, these results indicate that CD11c^+^ cells from infected middle-aged *Pla2g2d^+/+^* mice were more highly activated in vivo compared with young C57BL/6 mice, but that PLA~2~G2D has a relatively minor role in age-dependent differences in CD11c^+^ cell maturation and function.

These results show that the major effect of PLA~2~G2D is to increase levels of antiinflammatory lipid mediators, but changes in expression may also have indirect or direct effects on levels of cytokines and other inflammatory mediators. However, we observed no differences in expression of several proinflammatory molecules or IL-10, a cytokine with antiinflammatory properties, in the lungs of *Pla2g2d^+/+^* and *Pla2g2d^−/−^* mice at days 1 or 4 p.i. ([Fig. 6 E](#fig6){ref-type="fig"}). Thus, PLA~2~G2D has only small effects on general innate immune function in middle-aged mice and its absence largely affects only the expression of lipid mediators.

Absence of PLA~2~G2D enhances rDC migration to draining lymph nodes
-------------------------------------------------------------------

PGD~2~ inhibits the migration of airway DCs from lungs to the MLN in middle-aged naive and SARS-CoV--infected mice ([@bib30]; [@bib68]) and while levels of PGD~2~ decreased in *Pla2g2d^−/−^* mice, it was not known a priori whether this decrease was sufficient to correct the defect in rDC migration. To determine whether this was the case, we first instilled OVA-FITC intranasally (i.n.) into uninfected middle-aged *Pla2g2d^+/+^* and *Pla2g2d^−/−^* mice and analyzing MLN 18 h later for OVA-FITC^+^ rDCs, indicative of migration from the lungs. We observed that a higher frequency and number of rDCs migrated to the MLN in the absence of PLA~2~G2D ([Fig. 6 F](#fig6){ref-type="fig"}). We next investigated whether rDC migration was augmented in mice infected with SARS-CoV by instilling CFSE i.n. into middle-aged *Pla2g2d^+/+^* and *Pla2g2d^−/−^* mice 6 h before infection. 18 h p.i. MLN were harvested and analyzed for the frequency of rDCs that migrated from lungs (CD11c^+^MHCII^+^CFSE^+^ population). *Pla2g2d^−/−^* mice harbored a higher frequency and number of CFSE^+^ rDCs in MLN compared with *Pla2g2d ^+/+^* mice ([Fig. 6 G](#fig6){ref-type="fig"}). Migration of DCs from the site of infection to the MLN is mediated by chemokine receptor CCR7 binding to CCL19/21 ([@bib29]; [@bib20]) and DCs differentiated in the presence of PGD~2~ express lower levels of CCR7 ([@bib27]; [@bib68]). Consistent with higher expression of PLA~2~G2D and PGD~2~ in the lungs, *Pla2g2d^−/−^* rDCs expressed higher CCR7 surface levels than *Pla2g2d^+/+^* rDCs, contributing to enhanced rDC migration to the draining lymph nodes in uninfected and SARS-CoV--infected mice ([Fig. 6 H](#fig6){ref-type="fig"}).

Enhanced T cell responses and increased survival in SARS-CoV--infected *Pla2g2d^−/−^* mice
------------------------------------------------------------------------------------------

Having demonstrated superior migration of rDCs to the MLN in *Pla2g2d^−/−^* mice, we next assessed whether this translated into more robust virus-specific CD4 and CD8 T cell responses in infected lungs ([Fig. 7](#fig7){ref-type="fig"}). We addressed this possibility by examining the CD4 and CD8 T cell response in SARS-CoV--infected middle-aged *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice. A higher frequency and number of virus-specific (epitope S525-specific) CD8 T cell and (epitope N110-specific) CD4 T cells ([Fig. 7 A](#fig7){ref-type="fig"}) were present in the lungs of *Pla2g2d^−/−^* mice compared with *Pla2g2d^+/+^* mice. In addition, we also observed that CD8 T cells from *Pla2g2d^−/−^* compared with *Pla2g2d^+/+^* mice produced more IFN-γ on a per cell basis ([Fig. 7 B](#fig7){ref-type="fig"}), although there were no differences in the fraction of CD8 T cells that produced both IFN-γ and TNF ([Fig. 7 C](#fig7){ref-type="fig"}). Further, the absence of PLA~2~G2D augmented CD8 T cell cytolytic activity, measured in an in vivo killing assay ([Fig. 7 D](#fig7){ref-type="fig"}). To investigate if there was also a T cell--intrinsic defect in *Pla2g2d^+/+^* mice, we performed a set of adoptive transfer experiments, transferring splenocytes from uninfected *Pla2g2d^+/+^* or *Pla2g2d^−/−^* mice to CD45 disparate *Pla2g2d^−/−^* or *Pla2g2d^+/+^* mice, respectively, before SARS-CoV infection. In each case, the frequency of transferred CD8 T cells that expressed IFN-γ after peptide stimulation was similar to that of endogenous cells, indicating that the defects were T cell extrinsic ([Fig. 7 E](#fig7){ref-type="fig"}).

![**PLA~2~G2D dampening of the anti--SARS-CoV T cell response.** SARS-CoV--infected middle-aged *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice were analyzed for quantity and quality T cell responses in the lungs, as described in Materials and methods. (A) Representative flow plots showing frequency of virus-specific CD8 (S525 specific) and CD4 (N110 specific) T cell responses on day 6 after infection with 10^4^ PFU SARS-CoV. Summary data for frequency and total number of virus-specific T cells are shown in the bar graphs. Mean ± SEM; of two independent experiments, five mice/group. \*\*, P \< 0.01; \*\*\*, P \< 0.001, unpaired Student's *t* test. (B) Amount of IFN-γ produced on a per cell basis by CD8 T cells is depicted as MFI. Mean ± SEM; of two independent experiments, five mice/group. \*, P \< 0.05, unpaired Student's *t* test. (C) Representative data showing proportion of virus-specific T cells in the lungs expressing IFN-γ alone or IFN-γ and TNF. Mean ± SEM; of two independent experiments, five mice/group, unpaired Student's *t* test. (D) In vivo cytotoxicity was assessed on day 6 p.i and the percentage killing was determined as described in Materials and methods. Data show killing of target cells in the lungs of *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice. Mean ± SEM; three independent experiments, five mice/group. \*\*\*, P \< 0.001 (unpaired Student's *t* test). (E) Representative flow plots of virus-specific T cell responses in recipient *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice and summary data are shown. Mean ± SEM; two independent experiments with six mice/group. \*\*\*, P \< 0.001 (unpaired Student's *t* test).](JEM_20150632_Fig7){#fig7}

We next assessed whether these enhanced SARS-CoV--specific T cell responses decreased mortality after SARS-CoV infection. To this end, we infected middle-aged *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice with SARS-CoV and monitored survival ([Fig. 8 A](#fig8){ref-type="fig"}). More than 80% of *Pla2g2d^−/−^* mice survived the infection, whereas all *Pla2g2d^+/+^* mice died. Increased survival reflected enhanced kinetics of viral clearance in *Pla2g2d^−/−^* mice ([Fig. 8 B](#fig8){ref-type="fig"}), mediated by the more robust T cell response observed in these mice. In addition, decreased pathological changes were observed in the lungs of *Pla2g2d^−/−^* compared with *Pla2g2d^+/+^* mice. We detected no differences in the lungs of uninfected mice ([Fig. 8 C](#fig8){ref-type="fig"}, naive). *Pla2g2d^+/+^* mice showed much greater perivascular cuffing and cellular infiltration compared with *Pla2g2d^−/−^* mice by day 4 p.i. By day 6 p.i., multifocal inflammatory lesions around blood vessels and alveolar edema were significantly greater in *Pla2g2d^+/+^* mice, with few changes observed in *Pla2g2d^−/−^* mice.

![***Pla2g2d^−/−^* mice are protected from SARS-CoV infection.** Middle-aged *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice were infected with 10^4^ PFU of SARS-CoV i.n. (A) Mice were monitored daily for survival. Data are representative of two independent experiments, seven mice/group. P \< 0.001 (Kaplan-Meier log-rank survival tests). (B) Viral titers in the lungs of *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice at days 1, 4, and 6 p.i. are shown. Mean ± SEM; two independent experiments, seven mice/group. \*\*, P \< 0.01 (unpaired Student's *t* test). (C) Lung sections from *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice on day 6 p.i. were analyzed for pathological changes. Infiltrating cells (black arrows) and edema (asterisks) are shown. Histological changes were scored for inflammation and edema as described in Materials and methods. Mean ± SEM; two independent experiments, with three to five mice per group. \*, P \< 0.05; \*\*, P \< 0.01. Bars: (10×) 300 µm; (40×) 70 µm.](JEM_20150632_Fig8){#fig8}

Enhanced rDC migration to MLN and T cell responses in influenza A virus (IAV)-infected *Pla2g2d^−/−^* mice
----------------------------------------------------------------------------------------------------------

To determine whether elevated PLA~2~G2D levels in middle-aged mice affected the host immune response to other respiratory pathogens, we infected *Pla2g2d^−/−^* and *Pla2g2d^+/+^* mice with IAV (PR8 strain) and monitored rDC migration, T cell responses and survival. Both the frequency and number of rDCs were increased in the MLN of *Pla2g2d^−/−^* compared with *Pla2g2d^+/+^* mice when assessed at 18 h p.i. ([Fig. 9 A](#fig9){ref-type="fig"}). Consistent with increased rDC migration, we found that CD8 T cell responses were significantly higher in the lungs of *Pla2g2d*^−/−^ mice, when measured at 10 d p.i. ([Fig. 9 B](#fig9){ref-type="fig"}). Enhancement of the CD8 T cell response did not increase survival in IAV-infected mice ([Fig. 9 C](#fig9){ref-type="fig"}). This may occur because the CD8 T cell response is preserved to a greater extent in IAV compared with SARS-CoV--infected middle-aged *Pla2g2d^+/+^* mice, so that its augmentation has less of an effect on survival ([@bib68]).

![**PLA~2~G2D dampening of the anti-IAV T cell response.** Middle-aged *Pla2g2d^−/−^ or Pla2g2d^+/+^* mice were infected with 1020 tissue culture infectious units of IAV (PR8 strain) and analyzed for differences in rDC migration, CD8 T cell response in lungs, and survival. (A) Flow plots and frequency (left bar graph) and number (right bar graph) of airway DCs (CD11c^+^MHCII^+^CFSE^+^) that migrated from the lung to MLN, 18 h after IAV infection. Mean ± SEM; two independent experiments, four mice/group. \*\*, P \< 0.01, unpaired Student's *t* test. (B) Flow plots and summary data indicate the frequency and numbers of D^b^/PA224 tetramer^+^ CD8 T cells at 10 d p.i. Mean ± SEM; two independent experiments, four mice/group. \*, P \< 0.05; \*\*, P \< 0.01, unpaired Student's *t* test. (C) Percentage survival. Data are representative of two independent experiments, six mice/group. n.s.*,* not significant (Kaplan-Meier log-rank survival tests).](JEM_20150632_Fig9){#fig9}

Chronic oxidative stress mediates elevated PLA~2~G2D expression
---------------------------------------------------------------

Aging is accompanied by oxidative stress, which triggers lipid peroxidation ([@bib10]). A consequence of lipid peroxidation is increased expression of various PLA~2~s ([@bib7]), raising the possibility that increased oxidative stress in the middle-aged lung is a key factor in PLA~2~G2D up-regulation. To evaluate whether oxidative stress is increased in the lungs of middle-aged mice, we first measured the levels of malondialdehyde (MDA), a product of lipid peroxidation, and an indicator of oxidative stress ([@bib28]). Analyses of middle-aged compared with young mice revealed higher lung concentrations of MDA ([@bib34]), indicative of greater pulmonary oxidative stress ([Fig. 10 A](#fig10){ref-type="fig"}).

![**Oxidative stress induces expression of PLA~2~G2D.** A TBARS assay was used to measure lung MDA concentrations as a measure of oxidative stress in mouse lungs and human MDMs. (A) MDA concentration in the lungs of naive young and middle-aged mice. Mean ± SEM; two independent experiments, four mice/group. \*\*, P \< 0.01, unpaired Student's *t* test. (B) CD11c^+^ cells from the lungs of naive middle-aged mice that were treated with NAC or PBS (control) i.n. for 10 d, were separated using magnetic beads and expression of PLA~2~G2D was determined by qPCR and lung MDA concentrations were measured by TBARS assay. Mean ± SEM; two independent experiments, four mice/group. \*, P \< 0.05; \*\*, P \< 0.01 (unpaired Student's *t* test). (C and D) CD11c^+^ cells from the lungs of naive young mice that were treated with low doses of LPS or PBS (control) i.n. for 7 d were separated using magnetic beads. Expression of PLA~2~G2D (C) and other PLA2s (D) was determined by qPCR and lung MDA concentrations were measured by TBARS assay. Mean ± SEM; two independent experiments, six mice/group. n.s., not significant; \*, P \< 0.05; \*\*, P \< 0.01 (unpaired Student's *t* test). (E) Human MDMs were treated with low doses of LPS and MDA concentration (left) and *Pla2g2d* expression (right) were measured as before. Mean ± SEM; two independent experiments, three human PBMC samples with four replicates/sample. \*, P \< 0.05; \*\*\*, P \< 0.001, unpaired Student's *t* test.](JEM_20150632_Fig10){#fig10}

Oxidative stress can be countered by treatment with N-acetyl cysteine (NAC) and, as shown in [Fig. 10 B](#fig10){ref-type="fig"}, treatment of middle-aged mice with NAC for 10 d reduced MDA levels. Notably, NAC treatment also diminished levels of PLA~2~G2D mRNA in lung CD11c^+^ cells, suggesting that augmented PLA~2~G2D expression in middle-aged mice was related to oxidative stress ([Fig. 10 B](#fig10){ref-type="fig"}). Further, to induce oxidative stress in young mice, we treated them for seven days with a low dose of LPS (0.1 µg/mouse; [@bib37]). This dose has been shown to result in low level induction of proinflammatory mediators in murine macrophages ([@bib45]). Chronic LPS treatment resulted in higher concentrations of MDA in the lungs of mice compared with controls ([Fig. 10 C](#fig10){ref-type="fig"}). More importantly, inducing oxidative stress with LPS also increased mRNA levels of PLA~2~G2D ([Fig. 10 C](#fig10){ref-type="fig"}), but not of other PLA2s (PLA~2~G4, PLA~2~G2E, PLA~2~G10; [Fig. 10 D](#fig10){ref-type="fig"}) in lung CD11c^+^ cells.

To extend the clinical relevance of these results, we next determined whether chronic oxidative stress resulted in PLA~2~G2D up-regulation in human monocyte-derived macrophages (MDMs). For this purpose, PBMCs were treated with macrophage colony stimulating factor (M-CSF) for 4 d, and the cell-adherent population was incubated with M-CSF in the presence or absence of low levels of LPS (0.1 ng/ml) for an additional 1--10 d. PLA~2~G2D expression was then assessed. In agreement with previous work ([@bib46]), LPS exposure for 1 d did not result in increased PLA~2~G2D levels (unpublished data). However, we observed increased PLA~2~G2D expression after chronic LPS treatment (10 d), and this was accompanied by increases in MDA levels, indicative of higher oxidative stress ([Fig. 10 E](#fig10){ref-type="fig"}). Thus, chronic oxidative stress, a well-described aspect of aging in the human lung, results in increased PLA~2~G2D levels, which could contribute to age-dependent defects in the immune response to SARS-CoV and other respiratory pathogens.

DISCUSSION
==========

Although many infections are more severe in aged populations, SARS, and possibly MERS show remarkable age-dependent differences in outcomes such that young humans (less than 24 yr) all survived the infection, whereas 15% and 52% of middle-aged and aged individuals, respectively, succumbed ([@bib54]; [@bib5]; [@bib57]; [@bib1]). SARS-CoV--infected mice also show similar steep age-dependent changes in mortality, which we show is due, in large part, to increases in levels of a single secretory PLA~2~, PLA~2~G2D, as mice age. A hallmark of aging is lipid peroxidation and subsequent up-regulation of PLA~2~s ([@bib7]; [@bib63]; [@bib32]) and our results suggest that, in the lungs, levels of PLA~2~G2D singularly increase as mice age. PLA~2~G2D is considered an antiinflammatory/proresolving enzyme, suggesting its up-regulation is actually a measure used in the lung to counter the low-grade chronic inflammation that occurs with aging ([@bib22]; [@bib46]). In support of this notion, treatment with low doses of LPS, which induces oxidative stress and low-grade inflammation, resulted in PLA~2~G2D up-regulation both in CD11c^+^ cells in the mouse lung ([Fig. 10 C](#fig10){ref-type="fig"}) and in human monocyte-derived macrophages ([Fig. 10 E](#fig10){ref-type="fig"}). Further, interventions that diminish reactive oxygen species decreased PLA~2~G2D expression ([Fig. 10 B](#fig10){ref-type="fig"}). A recent study demonstrated the proresolving role of PLA~2~G2D in the setting of contact dermatitis in mice; in its absence, resolution was prolonged ([@bib46]). PLA~2~G2D would be expected to have similar effects in ameliorating disease in the context of autoimmune disease.

Increased PLA~2~G2D expression by lung CD11c^+^ cells results in up-regulation of several eicosanoids, with especially prominent effects on PGD~2~ production ([Figs. 4 D](#fig4){ref-type="fig"} and [5, E and H](#fig5){ref-type="fig"}). Activation of the PGD~2~--DP1 signaling axis on rDCs results in decreased CCR7 expression so that DP1 antagonism results in augmented rDC migration to the draining LN in uninfected and SARS-CoV--infected mice ([@bib30]; [@bib68]). Of note, inhibition of DC migration by PGD~2~/DP1 signaling is not confined to the lung, because, after skin invasion, *Schistoma mansonii* releases PGD~2~ to inhibit Langerhans cell migration to the draining LN, delaying the initial immune response ([@bib2]). Similar effects are observed in *Pla2g2d^−/−^* mice infected with either SARS-CoV or IAV, resulting in enhanced T cell responses ([Fig. 7, A, B, and D](#fig7){ref-type="fig"}, and [9 B](#fig9){ref-type="fig"}) and, in the case of SARS-CoV, improved survival ([Fig. 8 A](#fig8){ref-type="fig"}). In addition, PGD~2~ can also mediate its antiinflammatory effects through binding of 15d-PGJ~2~, a dehydration end product of PGD~2~, to a nuclear receptor PPARγ ([@bib33]).

Although we primarily focused on the role of PLA~2~G2D in increased PGD~2~ production, PLA~2~G2D is critical for the synthesis of additional antiinflammatory/proresolving molecules. PUFA--oxygenated metabolites with dedicated proresolving activities, including resolvins, protectins, and maresins (also called specialized proresolving mediators \[SPMs\]), are derived from ω3 fatty acids such as EPA and DHA ([@bib60]; [@bib8]; [@bib59]). PLA~2~G2D is known to release free PUFAs into a substrate pool that can be further mobilized to produce proresolving lipid mediators such as DHA-derived resolvin D1 and EPA-derived resolvin E1 among many others ([@bib60]; [@bib46]). Notably, EPA levels were higher in the lungs of uninfected middle-aged compared with young mice ([Fig. 4 B](#fig4){ref-type="fig"}), and both EPA and DHA production were higher in uninfected and infected *Pla2g2d^+/+^* mice compared with their *Pla2g~2~d^−/−^* counterparts ([Figs. 4 H](#fig4){ref-type="fig"} and [5 F](#fig5){ref-type="fig"}). However we failed to detect any resolvins or protectins, the downstream metabolites of EPA or DHA in the lungs of mice, possibly reflecting low levels of these molecules in lung tissue. Notably, although EPA is higher in middle-aged compared with young lungs (DHA is nearing to significance; P = 0.12; [Fig. 4 B](#fig4){ref-type="fig"}), SPMs are lower in the uninflamed peritoneum of aged compared with young mice ([@bib4]), suggesting that age-dependent differences in baseline levels of these molecules are organ-specific and could possibly contribute to disease-specific outcomes.

Our results also indicated that age-dependent differences in lung PLA~2~G2D levels were confined to CD11c^+^ cells. CD11c^+^ cells in draining LN also express PLA~2~G2D, and relative levels are much higher than in the lung ([@bib46]), but these do not change as mice age ([Fig. 2 F](#fig2){ref-type="fig"}). This specific effect of aging on pulmonary CD11c^+^ cells may reflect constant exposure to airborne antigens, most of which are innocuous. An immune response to these antigens would be undesirable and would contribute to allergic reactions and asthma. In contrast, PLA~2~G2D in lymph nodes might be expected to have a different role, namely to down-regulate proinflammatory responses, and thereby contribute to resolution of the immune response after pathogen control or allergic or autoimmune reactions.

A key question is why SARS-CoV--infected mice are especially affected by age-dependent changes in PLA~2~G2D expression. One unique feature of SARS is that maximal virus titers in mouse lungs are detected within 24 h after infection ([@bib21]), nearly coincident with the time of maximal migration of rDCs from the lungs to the DLNs. Furthermore, coronavirus replication results in extensive membrane remodeling with the formation of double membrane vesicles and other membranous structures, the sites of viral RNA synthesis and assembly ([@bib52]; [@bib36]; [@bib47]). This virus-induced reorganization of the host cell membrane causes the accumulation of cone-shaped lipids, specifically lysophosphatidylcholine (LPC) or phosphatidylethanolamine (PE; [@bib19]; [@bib39]; [@bib17]; [@bib43]; [@bib66]). Because PLA~2~G2D specifically mobilizes PE to release AA and DHA ([@bib46]), robust replication of SARS-CoV during the first 24 h of infection likely increases the amount of PLA~2~G2D substrate. Additionally, LPC and PE may form large lipid aggregates; most secreted phospholipases, including PLA~2~G2D, exhibit a tendency to show increased activity when the substrate is presented in this form ([@bib11]; [@bib25]). Thus, SARS-CoV infection results in enhanced release of AA into the eicosanoid pathway, which increases the concentration of PGD~2~ and downstream products of EPA and DHA, further dampening the immune response. Notably, similar processes may occur in patients with MERS-CoV infections, who also exhibit age-dependent increases in susceptibility ([@bib5]; [@bib57]; [@bib1]).

In conclusion, it is likely that in the absence of challenge with a pathogen such as SARS-CoV, elevated PLA~2~G2D expression benefits the host by increasing the level of various immunosuppressive lipid mediators such as PGD~2~, thereby dampening the response to environmental antigens. However in the context of an infection, the higher basal levels of PGD~2~ and other proresolving lipid mediators adversely affect the initiation of a protective innate immune response and ultimately adaptive immune response ([Fig. 10 E](#fig10){ref-type="fig"}). Thus, therapeutic interventions that increase the levels of proresolving lipid mediators might have undesirable effects in the context of infection. However, these results also suggest that PLA~2~G2D would serve as a useful therapeutic target in the lungs of patients after infection with SARS-CoV and perhaps other respiratory viral pathogens, including MERS-CoV. Short-term targeting of a single inducible PLA~2~ would avoid undesirable effects that might be observed by generalized inhibition of PLA~2~ function. Such drugs have been developed for some PLA~2~s ([@bib53]), although not yet for PLA~2~G2D, demonstrating the feasibility of this approach.

MATERIALS AND METHODS
=====================

### Mice, virus, and infection.

6 wk to 22 mo specific pathogen--free C57BL/6 mice were purchased from Charles River Laboratories or the National Cancer Institute (National Institutes of Health). *Pla2g2d*^−/−^ and *Pla2g2d*^+/+^ mice (H-2^b^) were generated as described ([@bib46]). After initial development, mice were backcrossed greater than 12 times to C57BL/6NCrSLc mice. *Pla2g2d*^+/+^ C57BL/6NCrSLc mice were used as controls for all experiments[.]{.ul} Mouse-adapted SARS-CoV (MA15) and IAV A/PR8/34 were obtained from Kanta Subbarao (National Institutes of Health) and Kevin Legge (University of Iowa, Iowa City, IA), respectively. For infections, mice were lightly anesthetized using isoflurane and infected i.n. with 1 × 10^4^ PFU SARS-CoV or 10^3^ TCID IAV in a 50 µl volume. All animal studies were approved by the University of Iowa Animal Care and Use Committee and meet stipulations of the Guide for the Care and Use of Laboratory Animals.

### Virus titration.

Lungs were harvested on the indicated days p.i. Tissue was homogenized in PBS using a manual homogenizer and titered on Vero E6 cells. For plaque assays, cells were fixed with 10% formaldehyde and stained with crystal violet 3 d p.i. Viral titers are expressed as PFU/gram.

### CD11c^+^ cell magnetic bead separation.

Lung single-cell suspensions were prepared as described. CD11c^+^ cells were separated using anti--mouse CD11c MicroBeads (Miltenyi Biotec) following the manufacturer's protocol.

### Microarray analysis.

CD11c^+^ cells from the lungs of young and middle-aged mice were separated as described above. RNA was purified using a mirVana kit (Life Technologies) according to the manufacturer's instructions. RNA samples were assessed for purity and quality using an Agilent 2100 Bioanalyzer. RNA for the microarray was processed using a NuGEN WT-Ovation Pico RNA Amplification System together with a NuGEN WT-Ovation Exon Module. Samples were hybridized and loaded onto MouseRef-8 v2.0 Expression BeadChip (Illumina). Arrays were scanned with a HiScan bead array system, and data were collected using GeneChip Operating Software.

Data from IIlumina MouseRef-8 v2.0 Expression BeadChip were normalized and median polished using Robust Multichip Average background correction with log~2~-adjusted values. After obtaining the log~2~ expression values for genes, significance testing was performed comparing the two groups (CD11c^+^ cells from lungs of young and middle-aged mice). False discovery rate was applied to all p-values to correct for multiple testing. Significance of expression differences was assessed using an false discovery rate (FDR) cutoff of 0.05 and a twofold change. Analysis and visualization of data and pathway analysis were performed using PartekGS software and Ingenuity Pathway Analysis software. Complete microarray data have been deposited at the Gene Expression Omnibus under accession no. [GSE71868](GSE71868).

### In situ CFSE and OVA-FITC staining.

CFSE and OVA-FITC were purchased from Molecular Probes. CFSE was diluted to a concentration of 8 mM in DMEM, and then administered i.n. (50 µl) 6 h before infection ([@bib41]; [@bib68]). OVA-FITC was dissolved in PBS, and 200 µg were administered i.n. in 75 µl.

### Lung and lymph node preparation.

Mice were euthanized at the indicated time points. After perfusion through the right ventricle with 5 ml of PBS, lungs and DLNs were removed. Lungs were diced into small pieces and digested in HBSS buffer containing 2% FCS, 25 mM HEPES, 1 mg/ml Collagenase D (Roche) and 0.1 mg/ml DNase (Roche) for 30 min at 37°C. After pressing through 70 µm nylon filters, lungs homogenates were spun down and treated with red blood cell lysis buffer. Cells were counted using a hemocytometer after dilution in 0.2% Trypan blue. Lymph nodes were dispersed and single-cell suspensions prepared using 70 µm nylon filters and counted.

### Lung histology.

Animals were anesthetized and transcardially perfused with PBS followed by zinc formalin. Lungs were removed, fixed in zinc formalin, and paraffin embedded. Sections were stained with hematoxylin and eosin and examined by light microscopy. Images were acquired using a BX53 microscope (Olympus), DP73 camera (Olympus), and CellSens software (Olympus). All sections were examined at room temperature using 10× or 40× objective lens. Sections were evaluated by a veterinary lung pathologist using postexamination masking techniques ([@bib26]). Sections were scored as follows: Inflammation, 1, normal range; 2, focal small patches of perivascular leukocyte aggregates (0--33% of lung); 3, multifocal patches of perivascular leukocyte aggregates (33--66% of lung); 4, widespread patches of perivascular leukocyte aggregates (\>67% of lung). Edema: 1, none; 2, minor (0--33% lung fields); 3, (33--66% lung fields); 4, (\>67% lung fields).

### Antibodies and flow cytometry.

The following monoclonal antibodies were used: PE or PercP Cy5.5-conjugated rat anti--mouse CD4 (RM4-5), FITC-conjugated rat anti--mouse CD8 (53--6.7), FITC or e450-conjugated hamster anti--mouse CD11c (HL3), APC or e450-conjugated rat anti--mouse CD11b, and rat anti--mouse CD16/32 (2.4G2) (eBioScience); PercP Cy5.5-conjugated hamster anti--mouse CD3 (145-2C11), PercP Cy5.5-conjugated rat anti--mouse I-A/I-E (M5/114.15.2), PercP Cy5.5 or PE-conjugated rat anti--mouseCD45 (30-F11), Alexa Fluor 647 or APC-conjugated rat anti--mouse IFN-γ (XMG1.2), and APC-conjugated rat anti--mouse TNF (MP6-XT22; BioLegend); PE or FITC-conjugated hamster anti--mouse CD80 (16-10A1), and FITC-conjugated rat anti--mouse CD40 (1C 10; BD). For PLA~2~G2D staining, rabbit anti--mouse PLA~2~G2D antibody ([@bib46]) was used as primary antibody, followed by staining with Alexa Fluor 647-conjugated goat anti--rabbit (Life Technologies).

For surface staining, 1 × 10^6^ cells were blocked with 1 µg of anti-CD16/32 antibody and stained with the indicated antibodies at 4°C, except for anti-CCR7 antibody, which was used at 37°C. After washing, cells were fixed using Cytofix Solution (BD). To detect antigen-specific T cells after SARS-CoV infection, 1 × 10^6^ cells were cultured in a 96-well round bottom plate in the presence of Brefeldin A and peptides corresponding to a CD8 T cell epitope (S525) or a CD4 T cell epitope (N110; Bio-Synthesis). To assess the functionality of CD11c^+^ cells, lung cells were prepared as described above and stimulated with LPS (1 µM), poly I:C (10 µg/ml), or vehicle (RP10) in the presence of Brefeldin A for 6 h at 37°C. To determine the frequency of CD11c^+^ cells expressing PLA~2~G2D, lung cells were incubated for 6 h at 37°C in the presence of Brefeldin A. Cells were then fixed and permeabilized using Cytofix/Cytoperm (BD) and labeled with anti--IFN-γ (T cells), anti-TNF (CD11c^+^ cells) or anti-PLA~2~G~2~D antibody. To detect antigen-specific T cells after IAV infection, lung cells were prepared as described above and PA224-specific CD8 T cells were identified by staining with H2D^b^/PA224 tetramer (National Institute of Allergy and Infectious Diseases Tetramer Facility, Atlanta, GA). Flow cytometric data were acquired using a FACSVerse (BD) and were analyzed using FlowJo software (Tree Star).

### PCR and primers.

Total RNA was extracted from CD11c^+^ and CD11c^−^ lung cells or whole lungs of naive or SARS-CoV--infected mice at the specified time p.i. using TRIzol reagent (Invitrogen). 2 µg of RNA were used for cDNA synthesis. 2 µl of cDNA were added to 23 µl of PCR cocktail containing 2XSYBR Green Master Mix (ABI) and 0.2 µM of forward and reverse primer. Amplification was performed in an ABI Prism 7700 thermocycler. The list of genes and of forward and reverse primers is shown in [Table S2](http://www.jem.org/cgi/content/full/jem.20150632/DC1){#supp2}. Cycle threshold ([@bib22]) values were normalized to those of the housekeeping gene hypoxanthine phosphoribosyltransferase (HPRT) by the following equation: Δ*Ct* = *Ct*~(gene\ of\ interest)~ − *Ct*~(HPRT).~ All results are shown as a ratio to HPRT calculated as 2^−(Δ*Ct*)^.

### LC/MS.

Lungs were harvested into 2 ml methanol and homogenized using a tissue grinder. 200 µl were transferred to a second tube and diluted to a final volume of 3 ml of 60% methanol (vol/vol). After incubation for 30 min at 37°C, 100 µl (0.1 ng/µl) of internal standard cocktail was added. Samples were diluted to a final concentration of 10% methanol (vol/vol) with water. For AA, PGD~2~, PGE~2~, PGF2α, TXB~2~, and 6-keto-PGF1α, internal standards were AA-d8, PGD~2~-d4, PGE~2~-d4, PGF2α-d4, TXB~2~-d4, and 6-keto-PGF1α-d4, respectively, all purchased from Cayman Chemical and added at the aforementioned concentration. For DHA and EPA, LTB~4~-d4 was used as the internal standard. Samples were centrifuged at 3,000 rpm for 10 min and the supernatant was subjected to solid phase extraction using a Strata-X 33 µm Polymeric Reversed Phase columns (60 mg/3 ml). Columns were purchased from Phenomenex, activated with 3 ml methanol, and washed with 3 ml water. Samples were eluted with 1 ml methanol, vacuum dried, and resuspended in 100 µl of mobile phase A. The analyses of PUFAs and their metabolites were performed using a Waters Acquity triple quadrupole mass spectrometer coupled with liquid chromatography (Acquity H class UPLC). Samples were then applied to an Acquity UPLC BEH C18 column (130 Å, 1.7 µm, 2.1 mm × 100 mm) and fractionated using a step gradient with mobile phase A (63:37:0.02% water/acetonitrile/formic acid) and mobile phase B (1:1 acetonitrile/isopropanol) at a flow rate of 300 µl/min for most analytes. For DHA and EPA, the mobile phase A was 65:35:0.01% methanol/water/acetic acid and mobile phase B was 100% methanol with 0.01% acetic acid. Columns were run at a flow rate of 250 µl/min. Primary standards were analyzed in parallel with the samples to enable quantification of the endogenous lipids. Detection of each lipid was performed by multiple reaction monitoring.

### Adoptive transfer of bulk splenocytes.

Naive CD45.1 (*Pla2g2d^+/+^*) or CD45.2 (*Pla2g2d^−/−^*) splenocytes were adoptively transferred by intravenous inoculation into CD45.2 (*Pla2g2d^−/−^*) or CD45.1 (*Pla2g2d^+/+^*) mice, respectively, at 50 × 10^6^ cells/mouse. 1 d after transfer, mice were infected with SARS-CoV i.n. Lungs were harvested 6 dpi and analyzed for virus-specific T cells as described in the preceding sections.

### In vivo cytotoxicity assay.

This assay was performed as described previously ([@bib6]). In brief, splenocytes from CD45.1 mice (*Pla2g2d^+/+^*, WT) were stained with high (1 µM, CFSE^hi^) or low (100 nM, CFSE^lo^) concentrations of CFSE. CFSE^hi^ cells were then pulsed with S525 (10 µM) at 37°C for 1 h. 5 × 10^5^ cells from each group (CFSE^hi^ and CFSE^lo^) were mixed together (10^6^ cells total) and transferred i.n. into mice CD45.2 *Pla2g2d^+/+^* and *Pla2g2d^-/-^* mice at 6 d p.i. Lungs were harvested 12 h later and analyzed for numbers of CFSE^hi^ and CFSE^lo^ CD45.1 cells. Percentage killing was calculated using the formula: 100 − (\[% peptide pulsed in infected/% unpulsed in infected\]/\[% peptide pulsed in uninfected/% unpulsed in uninfected\]) × 100) ([@bib6]).

### LPS treatment.

Young mice (6--8 wk) were treated i.n. with LPS (*E. coli* O111:B4) at 0.1 µg/mouse in 50 µl for 7 d.

### Antioxidant treatment.

Middle-aged mice (10--13 mo) were treated with *N*-Acetyl-[l]{.smallcaps}-Cysteine (Sigma-Aldrich; 100 mg/kg, i.p.) for 7 d.

### TBARS assay.

Pulmonary oxidative stress was measured using a TBARS assay kit according to the manufacturer's protocol (Cayman Chemicals). Data are expressed as the concentration of MDA ([@bib34]) in infected lungs.

### Human monocyte-derived macrophages.

Human peripheral blood samples from leukocyte reduction cones were obtained from anonymous volunteers that had consented to blood donation at the DeGowin Blood Center at the University of Iowa. Consent forms were approved by the University of Iowa's Institutional Review Board. To obtain monocytes, PBMCs were cultured in tissue culture plates at a seeding density of 1 × 10^6^ cells/ml in RP-10 media (RPMI-1640 medium \[Invitrogen\] with 10% FBS \[Atlanta Biologicals\] and 2 mM [l]{.smallcaps}-glutamine) supplemented with 5 ng/ml M-CSF (eBioscience) at 37°C with 5% CO~2~. After 4 d, the plates were washed with Hanks's balanced salt solution devoid of divalent cations (Invitrogen) to remove nonadherent cells. Adherent cells (predominantly MDMs) were then trypsinized and pelleted. Pelleted MDMs were resuspended at 1 × 10^6^ cells/ml in RP10 supplemented with M-CSF (5 ng/ml) and incubated at 37°C overnight. MDMs were subsequently seeded at a density of 5 × 10^5^/ml and incubated for 10 h at 37°C and 5% CO~2~. MDMs were then treated with 0.1 nM LPS (*E. coli* O111:B4; Sigma-Aldrich) and M-CSF (1 ng/ml) daily for 10 d.

### Statistics.

A Student's *t* test was used to analyze differences in mean values between groups except in the case of the microarray data. All results are expressed as mean ± SEM. P-values of \<0.05 were considered statistically significant. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. Differences in mortality were analyzed using Kaplan-Meier log-rank survival tests. Microarray data were subjected to multiple comparisons and FDR is shown, as described above.

### Online supplemental material.

Fig. S1 is a schematic representation of the effects of PLA~2~G2D in lungs of mice during SARS-CoV infection. Table S1 shows a list of genes in pulmonary CD11c^+^ cells expressed differentially in young and middle-aged mice. Table S2 shows qPCR primer sequences used in this study. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20150632/DC1>.
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